leadf
logo-loader
viewPreveCeutical Medical Inc.

PreveCeutical Medical Inc. receives first cannabis shipment at Australia lab

PreveCeutical Medical Inc. (CSE:PREV, OTCMKTS:PRVCF) CEO Stephen Van Deventer tells Proactive Investors the health sciences company received its first shipment of dried cannabis flowers and oils from Aurora Cannabis to their lab in Australia.

Van Deventer says PreveCeutical are now profiling three different cannabis strains for the application of soluble gel (Sol-gel) drug-delivery technology to cannabinoids. Van Deventer says it will take about 18 months until a product is available.

Quick facts: PreveCeutical Medical Inc.

Price: 0.03 CAD

CSE:PREV
Market: CSE
Market Cap: $14.76 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of PreveCeutical Medical Inc. named herein, including the promotion by the Company of PreveCeutical Medical Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

PreveCeutical Medical announces completion on analgesic program is near

PreveCeutical Medical (CSE:PREV-OTCQB: PRVCF) CEO Stephen Van Deventer joined Steve Darling from Proactive Vancouver with news the company’s current stage of research for its disulfide linker technology will be completed soon. Van Deventer telling Proactive about the program and what the next...

on 07/23/2020

2 min read